A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of Argemone mexicana plant is described. Also described is a purified Arabinogalactan-Protein (AGP) composition isolated from the leaves and/or stems of Argemone mexicana plant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN-.gamma. inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in Mouse Ear Swelling test (MEST).

 
Web www.patentalert.com

< 4-phenylbutyric acid controlled-release formulations for therapeutic use

< Methods for the stereoselective synthesis of substituted piperidines

> Phosphodiesterase 4 inhibitors

> Differential expression of molecules associated with acute stroke

~ 00243